Taylor Frigon Capital Management’s Procept Biorobotics PRCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.29M Buy
101,572
+12,864
+15% +$322K 1.07% 40
2026
Q1
$2.22M Buy
88,708
+16,697
+23% +$471K 1.26% 24
2025
Q4
$2.27M Sell
72,011
-815
-1% -$27K 1.15% 35
2025
Q3
$2.6M Buy
72,826
+24,175
+50% +$1.1M 1.29% 28
2025
Q2
$2.8M Sell
48,651
-3,429
-7% -$194K 1.49% 12
2025
Q1
$3.03M Sell
52,080
-2,287
-4% -$156K 1.81% 3
2024
Q4
$4.38M Sell
54,367
-19,923
-27% -$1.7M 2.22% 2
2024
Q3
$5.95M Sell
74,290
-7,590
-9% -$539K 2.97% 1
2024
Q2
$5M Sell
81,880
-675
-0.8% -$40.1K 2.38% 6
2024
Q1
$4.08M Sell
82,555
-39,020
-32% -$1.86M 1.94% 12
2023
Q4
$5.1M Sell
121,575
-2,887
-2% -$98.3K 2.56% 3
2023
Q3
$4.08M Buy
124,462
+55
+0% +$1.88K 2.27% 5
2023
Q2
$4.4M Buy
124,407
+49,665
+66% +$1.64M 2.15% 5
2023
Q1
$2.12M Sell
74,742
-1,287
-2% -$45.4K 1.16% 32
2022
Q4
$3.16M Sell
76,029
-4,590
-6% -$197K 1.79% 15
2022
Q3
$3.34M Buy
+80,619
New +$3.22M 1.74% 13

Other funds holding PRCT

Taylor Frigon Capital Management's PRCT Position: Q2 2026 in Review

Taylor Frigon Capital Management increased its Procept Biorobotics (PRCT) stake by 15% in Q2 2026, buying an estimated $322K and bringing the position to 101,572 shares worth $2.29M. The position accounts for 1.07% of the portfolio, ranked #40.

Taylor Frigon Capital Management first reported a position in PRCT in Q3 2022 and has held it in 16 quarters since. The position peaked at $5.95M in Q3 2024. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Taylor Frigon Capital Management held 101,572 shares of Procept Biorobotics worth $2.29M as of Q2 2026.
  • Taylor Frigon Capital Management bought 12,864 Procept Biorobotics shares in Q2 2026, an estimated $322K.
  • Procept Biorobotics made up 1.07% of Taylor Frigon Capital Management's portfolio in Q2 2026, its #40 holding.
  • Taylor Frigon Capital Management first reported a position in Procept Biorobotics in Q3 2022 and has held it in 16 quarters since.
  • Taylor Frigon Capital Management's Procept Biorobotics position peaked at $5.95M in Q3 2024.
  • 254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Taylor Frigon Capital Management's 13F filing for Q2 2026, filed 23 Jul 2026.